// App-Quantinova.ai

8537 : NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).

Researchers

Presenter

  • Dolores Isla

Principal Investigators

  • Maria Guirado

  • Bartomeu Massuti

  • Ramon De Las Penas

  • Ana Laura Ortega Granados

  • Manuel Domine

  • Raquel Marse Fabregat

  • Maria Angeles Sala Gonzalez

  • Alfredo Paredes

  • Teresa Moran

  • Sergio Vazquez Estevez

  • Juan Coves

  • Jose Luis Gonzalez Larriba

  • Miguel Sanchez

  • David Vicente

  • Nuria Farre

  • Luis Fernandez Fornos

  • Francisco Valcarcel

  • Mariano Provencio-Pulla

Medical Centers

  • Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain

  • Hospital De Sant Pau, Barcelona, Spain

  • Hospital General de Elche, Alicante, Spain

  • Albacete University Hospital, Albacete, Spain

  • Oncology Service Hospital Provincial of Castellon, Castellon, Spain

  • Medical Oncology, Complejo Hospitalario de Jaen, Jaen, Spain

  • Oncology Department and Translational Oncology Division, Fundacion Jimenez Diaz Hospital, Madrid, Spain

  • University Hospital Son Espases, Palma De Mallorca, Spain

  • Basurto University Hospital, Bilbao, Spain

  • Hospital Donostia, San Sebastian, Spain

  • Medical Oncology Department. Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain

  • Hospital Xeral-Calde de Lugo, Lugo, Spain

  • Hospital Son Llatzer, Palma De Mallorca, Spain

  • University Hospital La Paz, Madrid, Spain

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • General University Hospital de Elche, Elche, Spain

  • University Hospital Puerta De Hierro, Madrid, Spain

  • Hospital Puerta de Hierro, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Vinorelbine

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved